| Andrea Baowang Ajayi, MD | |
|
1800 Harrison St, 7th Floor, Oakland, CA 94612-3466 | |
| (510) 625-6262 | |
| (510) 625-6226 |
| Full Name | Andrea Baowang Ajayi |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 29 Years |
| Location | 1800 Harrison St, Oakland, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164413472 | NPI | - | NPPES |
| 00A726880 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A72668 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sutter Auburn Faith Hospital | Auburn, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
Oncothyreon Inc. today announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The trial, named INSPIRE (Stimuvax trial In Asian NSCLC Patients: Stimulating Immune Response), is anticipated to enroll approximately 420 patients in China, Hong Kong, South Korea, Singapore and Taiwan.
Using its unique online research platform, 23andMe, a leading personal genetics company, has found five significant genetic associations for hypothyroidism in the largest known genome-wide association study of hypothyroidism conducted to date. The details of the study are now available online in the journal PLoS ONE.
The COVID-19 pandemic is the most severe global health crisis of the 21st century. While media reports and policy directives tend to focus on the health and economic aspects of the pandemic, new research suggests that the pandemic is also destabilizing the fundamental relationship between citizens and the state.
A research study published in the February issue of Developmental Cell expands on previous studies by using adult animals to examine the role of a key gene known to be required for blood cell formation. Information gained from this research will be useful for future studies aimed at directing stem cell differentiation in a variety of potential therapeutic contexts.
ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.
› Verified 1 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Oncothyreon Inc. today announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The trial, named INSPIRE (Stimuvax trial In Asian NSCLC Patients: Stimulating Immune Response), is anticipated to enroll approximately 420 patients in China, Hong Kong, South Korea, Singapore and Taiwan.
Using its unique online research platform, 23andMe, a leading personal genetics company, has found five significant genetic associations for hypothyroidism in the largest known genome-wide association study of hypothyroidism conducted to date. The details of the study are now available online in the journal PLoS ONE.
The COVID-19 pandemic is the most severe global health crisis of the 21st century. While media reports and policy directives tend to focus on the health and economic aspects of the pandemic, new research suggests that the pandemic is also destabilizing the fundamental relationship between citizens and the state.
A research study published in the February issue of Developmental Cell expands on previous studies by using adult animals to examine the role of a key gene known to be required for blood cell formation. Information gained from this research will be useful for future studies aimed at directing stem cell differentiation in a variety of potential therapeutic contexts.
ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.
› Verified 1 days ago
| Entity Name | Team Physicians Of California Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447288345 PECOS PAC ID: 8224945084 Enrollment ID: O20040920000880 |
News Archive
Oncothyreon Inc. today announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The trial, named INSPIRE (Stimuvax trial In Asian NSCLC Patients: Stimulating Immune Response), is anticipated to enroll approximately 420 patients in China, Hong Kong, South Korea, Singapore and Taiwan.
Using its unique online research platform, 23andMe, a leading personal genetics company, has found five significant genetic associations for hypothyroidism in the largest known genome-wide association study of hypothyroidism conducted to date. The details of the study are now available online in the journal PLoS ONE.
The COVID-19 pandemic is the most severe global health crisis of the 21st century. While media reports and policy directives tend to focus on the health and economic aspects of the pandemic, new research suggests that the pandemic is also destabilizing the fundamental relationship between citizens and the state.
A research study published in the February issue of Developmental Cell expands on previous studies by using adult animals to examine the role of a key gene known to be required for blood cell formation. Information gained from this research will be useful for future studies aimed at directing stem cell differentiation in a variety of potential therapeutic contexts.
ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Baowang Ajayi, MD 5714 Eastview Dr, Stockton, CA 95212-2526 Ph: (209) 747-5918 | Andrea Baowang Ajayi, MD 1800 Harrison St, 7th Floor, Oakland, CA 94612-3466 Ph: (510) 625-6262 |
News Archive
Oncothyreon Inc. today announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax(R) (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The trial, named INSPIRE (Stimuvax trial In Asian NSCLC Patients: Stimulating Immune Response), is anticipated to enroll approximately 420 patients in China, Hong Kong, South Korea, Singapore and Taiwan.
Using its unique online research platform, 23andMe, a leading personal genetics company, has found five significant genetic associations for hypothyroidism in the largest known genome-wide association study of hypothyroidism conducted to date. The details of the study are now available online in the journal PLoS ONE.
The COVID-19 pandemic is the most severe global health crisis of the 21st century. While media reports and policy directives tend to focus on the health and economic aspects of the pandemic, new research suggests that the pandemic is also destabilizing the fundamental relationship between citizens and the state.
A research study published in the February issue of Developmental Cell expands on previous studies by using adult animals to examine the role of a key gene known to be required for blood cell formation. Information gained from this research will be useful for future studies aimed at directing stem cell differentiation in a variety of potential therapeutic contexts.
ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.
› Verified 1 days ago
Daniel Mantuani, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1506 4th Ave Apt 5, Apt 5, Oakland, CA 94606 Phone: 504-390-5474 | |
Jennifer I. Harris, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 | |
Benjamin J. Bonnes, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 | |
Richard J. Knight, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 275 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-1000 | |
Michael S. Gelfond, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 | |
Dr. Kayla Enriquez, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1411 E 31st St, Oakland, CA 94602 Phone: 510-437-4564 | |
Dr. Emily Meilan Sze, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Hawthorne Ave, Oakland, CA 94609 Phone: 510-869-2500 |